Literature DB >> 1736846

Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine.

O Rascol1, U Sabatini, F Chollet, P Celsis, J L Montastruc, J P Marc-Vergnes, A Rascol.   

Abstract

We have measured with single-photon emission tomography the regional cerebral blood flow changes that occurred in the supplementary motor areas and in the primary sensory motor areas during sequential finger-to-thumb opposition movements of the right hand in seven akinetic patients with Parkinson's disease and in nine normal volunteers. Parkinsonian patients were studied before ("off" condition) and after a subcutaneous injection of apomorphine hydrochloride which was able to switch them "on" (on condition). In normal volunteers and parkinsonian patients in the on condition, regional cerebral blood flow significantly increased in the supplementary motor areas and in the contralateral primary sensory motor cortex but not in the ipsilateral primary sensory motor cortex. On the contrary, no significant regional cerebral blood flow change was observed in these areas in parkinsonian patients in the off condition. These results support the hypothesis that a functional cortical motor area deafferentation is involved in the pathophysiological makeup of akinesia and that this abnormality is reversed by dopaminergic drugs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1736846     DOI: 10.1001/archneur.1992.00530260044017

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  40 in total

Review 1.  Imaging basal ganglia function.

Authors:  D J Brooks
Journal:  J Anat       Date:  2000-05       Impact factor: 2.610

2.  Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease.

Authors:  Gaetano Barbagallo; Maria Eugenia Caligiuri; Gennarina Arabia; Andrea Cherubini; Angela Lupo; Rita Nisticò; Maria Salsone; Fabiana Novellino; Maurizio Morelli; Giuseppe Lucio Cascini; Domenico Galea; Aldo Quattrone
Journal:  Hum Brain Mapp       Date:  2017-06-20       Impact factor: 5.038

Review 3.  Imaging in cell-based therapy for neurodegenerative diseases.

Authors:  Deniz Kirik; Nathalie Breysse; Tomas Björklund; Laurent Besret; Philippe Hantraye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

4.  Imaging the role of dopamine in health and disease Parkinson's disease as a lesion model.

Authors:  David J Brooks
Journal:  Wien Klin Wochenschr       Date:  2006-10       Impact factor: 1.704

5.  Changes in brain functional activation during resting and locomotor states after unilateral nigrostriatal damage in rats.

Authors:  J Yang; T R Sadler; T K Givrad; J-M I Maarek; D P Holschneider
Journal:  Neuroimage       Date:  2007-03-23       Impact factor: 6.556

6.  Micrographia in Parkinson's disease: the effect of providing external cues.

Authors:  R M Oliveira; J M Gurd; P Nixon; J C Marshall; R E Passingham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

Review 7.  Pathophysiology of somatosensory abnormalities in Parkinson disease.

Authors:  Antonella Conte; Nashaba Khan; Giovanni Defazio; John C Rothwell; Alfredo Berardelli
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

8.  Primary motor cortex of the parkinsonian monkey: altered encoding of active movement.

Authors:  Benjamin Pasquereau; Mahlon R DeLong; Robert S Turner
Journal:  Brain       Date:  2015-10-21       Impact factor: 13.501

9.  GluN2A and GluN2B NMDA receptor subunits differentially modulate striatal output pathways and contribute to levodopa-induced abnormal involuntary movements in dyskinetic rats.

Authors:  Omar S Mabrouk; Flora Mela; Mariangela Calcagno; Mirco Budri; Riccardo Viaro; Andrzej Dekundy; Christopher G Parsons; Yves P Auberson; Michele Morari
Journal:  ACS Chem Neurosci       Date:  2013-04-23       Impact factor: 4.418

10.  Non-dominant hand movement facilitates the frontal N30 somatosensory evoked potential.

Authors:  Wynn Legon; Jennifer K Dionne; Sean K Meehan; W Richard Staines
Journal:  BMC Neurosci       Date:  2010-09-07       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.